Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101927876 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OR2L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAV2-AS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928009 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927849 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNF1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DUSP15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR2M4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PANK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C9orf40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC5A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEZ6L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCAIM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on